Viral reservoirs/transient infection in HIV/AIDS: Where are we now and where should we go?: Summary of the June 13-14, 2002 think tank meeting

AIDS Research and Human Retroviruses

Volumn 19, Issue 4, 2003, Pages 333-344

  Wassef, Nabila M ^a,b   Young, Janet ^a   Miller, Roger ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b Division of AIDS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; BETA CHEMOKINE; DIDANOSINE; HYDROXYUREA; INTERLEUKIN 2; INTERLEUKIN 6; OKT 3; TUMOR NECROSIS FACTOR ALPHA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CELLULAR IMMUNITY; CHROMATIN; CONFERENCE PAPER; CYTOTOXIC T LYMPHOCYTE; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DRUG POTENCY; ERADICATION THERAPY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOREGULATION; LATENT PERIOD; MACACA; MACROPHAGE; MEDICAL RESEARCH; MONOCYTE; NONHUMAN; POPULATION DYNAMICS; PRIORITY JOURNAL; RECTUM MUCOSA; SIMIAN IMMUNODEFICIENCY VIRUS; TREATMENT WITHDRAWAL; VAGINITIS; VIRUS DETECTION; VIRUS DIAGNOSIS; VIRUS REPLICATION;

ANIMALS; DISEASE RESERVOIRS; HIV INFECTIONS; HIV-1; HUMANS; RESEARCH; VIRUS LATENCY; VIRUS REPLICATION;

EID: 0037393058     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922203764969546     Document Type: Conference Paper

References (20)

1. Sharkey ME and Stevenson M: Two long terminal repeat circles and persistent HIV-1 replication. Curr Opin Infect Dis 2001;14:5-11.
2. Chun TF, Finzi D, Margolick J, Chadwick K, Schwartz D, and Siliciano RF: In vivo fate of HIV-1-infected T cells: Quantitative analysis of the transition to stable latency. Nat Med 1995;1:1284-1290.
3. Blankson JN, Persaud D, and Siliciano RF: The challenge of viral reservoirs in HIV-1 infection. Annu Rev Med 2002;53:557-593.
4. + lymphocytes after HIV antiretroviral therapy reflects redistribution from lymphoid tissues. J Clin Invest 1999;103:1391-1398.
5. Hockett RD, Kilby JM, Derdeyn, et al.: Constant mean viral copy number per infected cell in tissues regardless of high, low, or undetectable plasma HIV RNA. J Exp Med 1999;189:1545-1554.
6. Derdeyn CA, Kilby JM, Miralles GD, et al.: Evaluation of distinct blood lymphocyte populations in human immunodeficiency virus type 1-infected subjects in the absence or presence of effective therapy. J Infect Dis 1999;180:1851-1862.
7. Kulkosky J, Nunnari G, Otero M, et al: Intensification and stimulatory therapy for HIV-1 reservoirs in infected individuals on virally-suppressive HAART. J Infect Dis 2002;186:1403-1411.
8. Chun TW and Fauci AS: Latent reservoirs of HIV: Obstacles to the eradication of virus. Proc Natl Acad Sci USA 1999;96:10958-10961.
9. + T cells: Implications for the development of therapeutic strategies. Proc Natl Acad Sci USA 2001;98:253-258.
10. Jordan A, Defechereux P, and Verdin E: The site of HIV-1 integration in the human genome determines basal transcriptional activity and response to Tat transactivation. EMBO J 2001;20:1726-1738.
11. He G and Margolis DM: Counterregulation of chromatin deacetylation and histone deacetylase occupancy at the integrated promotor of human immunodeficiency virus type 1 (HIV-1) by the HIV-1 repressor YY1 and HIV-1 activator Tat. Mol Cell Biol 2002;22:2965-2973.
12. Sahu GK, Chen JJ, Huang JC, Ramsey KM, and Cloyd MW: Transient or occult HIV-1 infection in high-risk adults. AIDS 2001;15:1175-1177.
13. Schmechel SC, Russell N, Hladik F, Lang J, Wilson A, Ha R, Dresbien A, and McElrath MJ: Immune defense against HIV-1 infection in HIV-1-exposed seronegative persons. Immunol Lett 2001;79:21-27.
14. Bryson YJ, Pang S, Wei LS, Dickover R, Diagne A, and Chen IS: Clearance of HIV infection in a perinatally infected infant. N Engl J Med 1995;332:833-838.
15. Yusim K, Kesmir C, Gaschen B, Addo MM, Altfeld M, et al.: Clustering patterns of cytotoxic T-lymphocyte epitopes in human immunodeficiency virus type 1 (HIV-1) proteins reveal imprints of immune evasion on HIV-1 global variation. J Virol 2002;76:8757-8768.
16. Miller CJ, Marthas M, Torten J, et al.: Intravaginal inoculation of rhesus macaques with cell-free simian immunodeficiency virus results in persistent or transient viremia. J Virol 1994;68:6391-6400.
17. + T cell proliferative responses in rhesus macaques that were transiently viremic after intravaginal inoculation of SIV. J Virol 1998;72:10029-10035.
18. O'Connell-Rodwell CE, Burns SM, Bachmann MH, and Contag CH: Bioluminescent indicators for in vivo measurements of gene expression. Trends Biotechnol 2002;20:S19-S23.
19. Contag CH and Bachman MH: Advances in in vivo bioluminescence imaging of gene expression. Annu Rev Biomed Eng 2002;4:235-260.
20. Patterson BK, McCallister S, Schutz M, et al.: Persistence of intracellular HIV-1 mRNA correlates with HIV-1-specific immune responses in infected subjects on stable HAART. AIDS 2001;15:1635-1641.